The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Farzaneh-far Ramin since 2019.
The trader's CIK number is 1688195.
At the time of the last reporting, Farzaneh-far Ramin was the Chief Medical Officer of Ra Pharmaceuticals, Inc.. (stock ticker symbol RARX).
Also see all insider trading activities at Ra Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | RARX | 0 | $0 | 31,785 | $1,469,822 | 31,785 | $177,993 |
| 2019 | RARX | 0 | $0 | 74,165 | $2,634,507 | 84,582 | $415,317 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-03-16 | RARX | Option Ex | 10,595 | 5.60 | 59,331 |
| 2020-03-16 | RARX | Sale | 10,595 | 45.16 | 478,523 |
| 2020-02-18 | RARX | Option Ex | 10,595 | 5.60 | 59,331 |
| 2020-02-18 | RARX | Sale | 10,595 | 46.61 | 493,854 |
| 2020-01-15 | RARX | Option Ex | 10,595 | 5.60 | 59,331 |
| 2020-01-15 | RARX | Sale | 10,595 | 46.95 | 497,445 |
| 2019-12-16 | RARX | Option Ex | 10,595 | 5.60 | 59,331 |
| 2019-12-16 | RARX | Sale | 10,595 | 47.23 | 500,348 |
| 2019-11-15 | RARX | Option Ex | 10,595 | 5.60 | 59,331 |
| 2019-11-15 | RARX | Sale | 10,595 | 46.66 | 494,320 |
| 2019-10-15 | RARX | Option Ex | 10,595 | 5.60 | 59,331 |
| 2019-10-15 | RARX | Sale | 10,595 | 46.89 | 496,767 |
| 2019-09-16 | RARX | Sale | 10,595 | 25.26 | 267,672 |
| 2019-09-16 | RARX | Option Ex | 10,595 | 5.60 | 59,331 |
| 2019-08-23 | RARX | Option Ex | 10,595 | 5.60 | 59,331 |
| 2019-08-23 | RARX | Sale | 10,595 | 27.77 | 294,223 |
| 2019-07-15 | RARX | Sale | 10,595 | 33.13 | 350,991 |
| 2019-07-15 | RARX | Option Ex | 10,595 | 5.60 | 59,331 |
| 2019-06-17 | RARX | Option Ex | 10,595 | 5.60 | 59,331 |
| 2019-06-17 | RARX | Sale | 10,595 | 21.73 | 230,186 |
| 2019-02-01 | RARX | Option Ex | 10,417 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Farzaneh-far Ramin (Chief Medical Officer of Ra Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.